Tissue Engineering and Regeneration: Technologies and Global Markets

Tissue Engineering and Regeneration: Technologies and Global Markets

Report Code: HLC101B

Publish Date: Aug 2014

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate(CAGR) of 22.3%.

Report Includes

  • An overview of the global market for tissue engineering and regeneration, and related technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on the specific drivers, trends, and challenges for different segments of the market.
  • Valuable insight into future trends, details on products, and information on therapies available in the field of tissue engineering.
  • Analysis of the competitive environments, including new and potential markets for novel therapies and treatments.  
  • Comprehensive profiles of major players in the industry.

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes key technologies involved in stem cell therapies and cell therapies. It analyzes the clinical trials and patents conducted in respective geographies. The report is an in-depth analysis of key companies operating in the global tissue engineering and regeneration market. It includes in-depth patent analysis that focuses on providing extensive technological trends across years and across regions, including the U.S., Europe and Japan.

The tissue engineering and regeneration market is mainly segmented into three classes: synthetic, genetically modified and biological materials. Synthetic materials are further categorized into biodegradable synthetic polymers, scaffold (medical poly lactic acid), artificial vascular graft materials and hydrogeltechnology. The biologically derived materials are segmented into, xenogenic tissue and collagen. The ablation device application market is further segmented on the basis of various applications for in-depth analysis of technology markets. The market study is detailed for application based on procedures, as well as its further implication on the therapeutic area. These two segments are also discussed in detailed for the forecast period. The market is segmented by region into the Americas, Europe, Asia-Pacific and ROW. Companies profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, CeraPedics, Cook Biotech, CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market, and in the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to help market players make strategic decision. She holds an MBA in Marketing.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Tissue Engineering and Regeneration: Technologies and Global Markets171Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: TISSUE ENGINEERING AND REGENERATION27Free
Chapter- 4: TISSUE ENGINEERING AND REGENERATION MARKET ANALYSIS BY TECHNOLOGY16Free
Chapter- 5: TISSUE ENGINEERING AND REGENERATION MARKET ANALYSIS BY MATERIALS19Free
Chapter- 6: TISSUE ENGINEERING AND REGENERATION MARKET BY APPLICATION38Free
Chapter- 7: TISSUE ENGINEERING AND REGENERATION MARKET BY REGION 27Free
Chapter- 8: COMPETITIVE LANDSCAPE10Free
Chapter- 9: PATENT ANALYSIS7Free
Chapter- 10: C. CRAMER & CO. GMBH18Free
Chapter- 11: PATENTS3Free

Related Reports

Regenerative Medicines: Bone and Joint Applications

Published - Jun 2013 | Publisher - Kevin Gainer | Code - PHM032C

The U.S. market for regenerative medicine products used in bone and joint applications was estimated to total $2.72 billion in 2012 and is projected to increase to $2.73 billion in 2013. The market should total nearly $3.9 billion by 2018 and have a five-year compound annual growth rate (CAGR) of 7.3%.

Global Markets for Dental Consumables and Prosthetics

Published - Mar 2011 | Publisher - Melissa Elder | Code - HLC087A

The overall value of the global dental consumables and prosthetics market was worth $15.9 billion in 2010, up from $15.7 billion in 2009.  The market is estimated to reach $18.5 billion in 2015, at a compound annual growth rate (CAGR) of 3.1% over the forecast period.

Organ and Tissue Transplantation and Alternatives

Published - Jan 2011 | Publisher - Peggy Lehr | Code - HLC012E

The global market for transplantation products, devices, and pharmaceuticals was valued at nearly $54 billion in 2010 and is projected to grow at an 8.3% compound annual growth rate (CAGR) to reach $80 billion in 2015.

Advanced Orthopedic Technologies, Implants and Regenerative Products

Published - Jan 2011 | Publisher - Melissa Elder | Code - HLC052B

The total market for advanced orthopedic technology and products was estimated to exceed $28 billion in 2010. New technologies and an increasingly older population are two of the major driving forces within the market. By 2015, the advanced orthopedic technology and product market is likely to reach $32.4 billion, with a compound annual growth rate (CAGR) from 2010 to 2015 of 2.7%.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 123

  • Summary Table: GLOBAL TISSUE ENGINEERING AND REGENERATION MARKET BY REGION, THROUGH 2019
  • Table 1: REGULATORY APPROVAL DIFFERENCES BETWEEN THE U.S. AND EUROPE
  • Table 2: HEALTHCARE PROVISIONS BY COUNTRY, 2014
  • Table 3: U.S. CLINICAL TRIALS FOR TISSUE ENGINEERING
  • Table 4: U.S. CLINICAL TRIALS FOR TISSUE ENGINEERING
  • Table 5: U.S. TERMINATED CLINICAL TRIALS
  • Table 6: EUROPEAN CLINICAL TRIALS FOR TISSUE ENGINEERING
  • Table 7: U.S. UNINTENTIONAL INJURIES FACTS, 2013
  • Table 8: REGENERATIVE MEDICINE INDUSTRY TRENDS, 2007–2011
  • Table 9: GLOBAL TISSUE ENGINEERING AND REGENERATION MARKET BY TECHNOLOGY, THROUGH 2019
  • Table 10: GLOBAL STEM CELL TISSUE ENGINEERING AND REGENERATION MARKET BY REGION, THROUGH 2019
Sample Report

Recent Reports

Anesthesia and Respiratory Devices: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - HLC167E

The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.

Tissue Engineering and Regeneration: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC101E

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

6G in Healthcare: Global Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC306A

This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.

Healthcare Innovation in the GCC

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC307A

The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.

Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC305A

This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.

Published - Jan-2012| Analyst - Marianna Tcherpakov| Code - HLC101A

Report Highlights

The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Tissue Engineering and Regeneration: Technologies and Global Markets
Customize Report